This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sáenz Robles, M T
Right arrow Articles by Van Dyke, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sáenz Robles, M T
Right arrow Articles by Van Dyke, T

 Previous Article  |  Next Article 

Mol Cell Biol. 1994 April; 14(4): 2686-2698

Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen.

M T Sáenz Robles, H Symonds, J Chen and T Van Dyke

Department of Biological Sciences, University of Pittsburgh, Pennsylvania.

ABSTRACT

The ability of simian virus 40-encoded large T antigen to disrupt the growth control of a variety of cell types is related to its ability to interfere with certain cellular proteins, such as p53 and the retinoblastoma susceptibility gene product (pRB). We have used wild-type and mutant forms of T antigen in transgenic mice to dissect the roles of pRB, p53, and other cellular proteins in tumorigenesis of different cell types. In this study, using a cell-specific promoter to target expression specifically to brain epithelium (the choroid plexus) and to B and T lymphoid cells, we characterize the tumorigenic capacity of a T-antigen fragment that comprises only the amino-terminal 121 residues. This fragment (dl1137) retains the ability to interact with pRB and p107 but lacks the p53-binding domain. While loss of the p53-binding region results in loss of the capacity to induce lymphoid abnormalities, dl1137 retains the ability to induce choroid plexus tumors that are histologically indistinguishable from those induced by wild-type T antigen. Tumors induced by dl1137 develop much more slowly, however, reaching an end point at around 8 months of age rather than at 1 to 2 months. Analysis of tumor progression indicates that tumor induction by dl1137 does not require secondary genetic or epigenetic events. Rather, the tumor growth rate is significantly slowed, indicating that the T-antigen C-terminal region contributes to tumor progression in this cell type. In contrast, the pRB-binding region appears essential for tumorigenesis as mutation of residue 107, known to disrupt pRB and p107 binding to wild-type T antigen, abolishes the ability of the dl1137 protein to induce growth abnormalities in the brain.

Mol Cell Biol. 1994 April; 14(4): 2686-2698




This article has been cited by other articles:

  • Lu, X., Yang, C., Hill, R., Yin, C., Hollander, M. C., Fornace, A. J. Jr, Van Dyke, T. (2008). Inactivation of gadd45a Sensitizes Epithelial Cancer Cells to Ionizing Radiation In vivo Resulting in Prolonged Survival. Cancer Res. 68: 3579-3583 [Abstract] [Full Text]  
  • Saenz-Robles, M. T., Markovics, J. A., Chong, J.-L., Opavsky, R., Whitehead, R. H., Leone, G., Pipas, J. M. (2007). Intestinal Hyperplasia Induced by Simian Virus 40 Large Tumor Antigen Requires E2F2. J. Virol. 81: 13191-13199 [Abstract] [Full Text]  
  • Gjoerup, O. V., Wu, J., Chandler-Militello, D., Williams, G. L., Zhao, J., Schaffhausen, B., Jat, P. S., Roberts, T. M. (2007). Surveillance mechanism linking Bub1 loss to the p53 pathway. Proc. Natl. Acad. Sci. USA 104: 8334-8339 [Abstract] [Full Text]  
  • Chai, J., Lu, X., Godfrey, V., Fletcher, C., Roberts, C. W.M., Van Dyke, T., Weissman, B. E. (2007). Tumor-Specific Cooperation of Retinoblastoma Protein Family and Snf5 Inactivation. Cancer Res. 67: 3002-3009 [Abstract] [Full Text]  
  • Brubaker, L. M., Bullitt, E., Yin, C., Van Dyke, T., Lin, W. (2005). Magnetic Resonance Angiography Visualization of Abnormal Tumor Vasculature in Genetically Engineered Mice. Cancer Res. 65: 8218-8223 [Abstract] [Full Text]  
  • Markovics, J. A., Carroll, P. A., Robles, M. T. S., Pope, H., Coopersmith, C. M., Pipas, J. M. (2005). Intestinal Dysplasia Induced by Simian Virus 40 T Antigen Is Independent of p53. J. Virol. 79: 7492-7502 [Abstract] [Full Text]  
  • Albright, C. D., Salganik, R. I., Van Dyke, T. (2004). Dietary Depletion of Vitamin E and Vitamin A Inhibits Mammary Tumor Growth and Metastasis in Transgenic Mice. J. Nutr. 134: 1139-1144 [Abstract] [Full Text]  
  • Tsai, K. Y., MacPherson, D., Rubinson, D. A., Nikitin, A. Yu., Bronson, R., Mercer, K. L., Crowley, D., Jacks, T. (2002). ARF mutation accelerates pituitary tumor development in Rb+/- mice. Proc. Natl. Acad. Sci. USA 99: 16865-16870 [Abstract] [Full Text]  
  • Cole, S. L., Tevethia, M. J. (2002). Simian Virus 40 Large T Antigen and Two Independent T-Antigen Segments Sensitize Cells to Apoptosis following Genotoxic Damage. J. Virol. 76: 8420-8432 [Abstract] [Full Text]  
  • Kim, J. Y.H., Koralnik, I. J., LeFave, M., Segal, R. A., Pfister, L.-A., Pomeroy, S. L. (2002). Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences. Neuro Oncol Duke 4: 165-170 [Abstract]  
  • Tolbert, D., Lu, X., Yin, C., Tantama, M., Van Dyke, T. (2002). p19ARF Is Dispensable for Oncogenic Stress-Induced p53-Mediated Apoptosis and Tumor Suppression In Vivo. Mol. Cell. Biol. 22: 370-377 [Abstract] [Full Text]  
  • Lu, X., Magrane, G., Yin, C., Louis, D. N., Gray, J., Van Dyke, T. (2001). Selective Inactivation of p53 Facilitates Mouse Epithelial Tumor Progression without Chromosomal Instability. Mol. Cell. Biol. 21: 6017-6030 [Abstract] [Full Text]  
  • Salganik, R. I., Albright, C. D., Rodgers, J., Kim, J., Zeisel, S. H., Sivashinskiy, M. S., Van Dyke, T. A. (2000). Dietary antioxidant depletion: enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice. Carcinogenesis 21: 909-914 [Abstract] [Full Text]  
  • Liao, M.-J., Yin, C., Barlow, C., Wynshaw-Boris, A., van Dyke, T. (1999). Atm Is Dispensable for p53 Apoptosis and Tumor Suppression Triggered by Cell Cycle Dysfunction. Mol. Cell. Biol. 19: 3095-3102 [Abstract] [Full Text]  
  • Butel, J. S., Lednicky, J. A. (1999). Cell and Molecular Biology of Simian Virus 40: Implications for Human Infections and Disease. JNCI J Natl Cancer Inst 91: 119a-134a [Abstract] [Full Text]  
  • (1997). Extended Abstracts. Toxicol Pathol 25: 674-696  
  • Cooper, M. J., Lippa, M., Payne, J. M., Hatzivassiliou, G., Reifenberg, E., Fayazi, B., Perales, J. C., Morrison, L. J., Templeton, D., Piekarz, R. L., Tan, J. (1997). Safety-modified episomal vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 94: 6450-6455 [Abstract] [Full Text]  
  • Bowman, T, Symonds, H, Gu, L, Yin, C, Oren, M, Van Dyke, T (1996). Tissue-specific inactivation of p53 tumor suppression in the mouse.. Genes Dev. 10: 826-835 [Abstract]  
  • Kernohan, N. M., Hupp, T. R., Lane, D. P. (1996). Modification of an N-terminal Regulatory Domain of T Antigen Restores p53-T Antigen Complex Formation in the Absence of an Essential Metal Ion Cofactor. J. Biol. Chem. 271: 4954-4960 [Abstract] [Full Text]  
  • Pan, H, Griep, A E (1995). Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development.. Genes Dev. 9: 2157-2169 [Abstract]  
  • Li, Q., Karam, S. M., Gordon, J. I. (1995). Simian Virus 40 T Antigen-induced Amplification of Pre-parietal Cells in Transgenic Mice. J. Biol. Chem. 270: 15777-15788 [Abstract] [Full Text]  
  • Hartwell, L., Kastan, M. (1994). Cell cycle control and cancer. Science 266: 1821-1828 [Abstract]  
  • Symonds, H., Krall, L., Remington, L., Saenz Robles, M., Jacks, T., Van Dyke, T. (1994). p53-Dependent Apoptosis In Vivo: Impact of p53 Inactivation on Tumorigenesis. Cold Spring Harb Symp Quant Biol 59: 247-257 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»